Cognition-enhancing drugs

被引:58
作者
Mehlman, MJ [1 ]
机构
[1] Case Western Reserve Univ, Law Med Ctr, Sch Law, Cleveland, OH 44106 USA
关键词
D O I
10.1111/j.0887-378X.2004.00319.x
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
New drugs that enhance cognition in cognitively healthy individuals present difficult public policy challenges. While their use is not inherently unethical, steps must be taken to ensure that they are safe, that they are widely available to promote equality of opportunity, and that individuals are free to decide whether or not to use them.
引用
收藏
页码:483 / 506
页数:24
相关论文
共 46 条
[1]  
*ALL, 2004, BOT LAB IND
[2]  
[Anonymous], 2003, WONDERGENES GENETIC
[3]  
[Anonymous], WELCOME MONKEY HOUSE
[4]   Student perceptions of methylphenidate abuse at a public liberal arts college [J].
Babcock, Q ;
Byrne, T .
JOURNAL OF AMERICAN COLLEGE HEALTH, 2000, 49 (03) :143-145
[5]   EFFECT OF BETA-BLOCKADE AND BETA-STIMULATION ON STAGE FRIGHT [J].
BRANTIGAN, CO ;
BRANTIGAN, TA ;
JOSEPH, N .
AMERICAN JOURNAL OF MEDICINE, 1982, 72 (01) :88-94
[6]  
BUCHANAN A., 2000, From Chance to Choice: Genetics andJustice
[7]   A double-blind, placebo-controlled investigation of the efficacy of modafinil for sustaining the alertness and performance of aviators: a helicopter simulator study [J].
Caldwell, JA ;
Caldwell, JL ;
Smythe, NK ;
Hall, KK .
PSYCHOPHARMACOLOGY, 2000, 150 (03) :272-282
[8]  
*CEPH INC, 2003, INV OV
[9]  
*CTR SCI PUBL INT, 2003, HLTH ACT NEWSL CAFF
[10]   Emerging ethical issues in neuroscience [J].
Farah, MJ .
NATURE NEUROSCIENCE, 2002, 5 (11) :1123-1129